MedTrace Logo

Comparing OTC Acne Treatment to Prescription Regimen

NCT01237821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2019-07-16

Study results available
· View outcomes & findings →

Summary

This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

BenzaClin

Topical, 1% Clindamycin/5% Benzoyl Peroxide, BID, 12 weeks

DRUG

Effaclar

Topical, Bid, 12 weeks

Sponsors & Collaborators

  • Loreal USA

    collaborator INDUSTRY

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Christian Oresajo, PhD · Loreal USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-08-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01237821 on ClinicalTrials.gov